FEMA, an agency within the US Department of Homeland Security, awarded contracts to manufacturers in South Korea last week to provide approximately 750,000 tests, according to a FEMA spokesperson and federal records.
Over the weekend, the first shipment of 150,000 tests were delivered to the US by SolGent. The next shipment of 600,000 tests will arrive by April 15. They are being provided by two South Korea-based companies, SD Biosensor and Osang Healthcare.
The intent, the FEMA spokesperson said, is to move the tests to a cold storage facility in Louisville, Kentucky, for distribution. Urgent needs will be given priority, according to a FEMA advisory obtained by CNN.
The Trump administration has waffled on its praise of South Korea’s testing capabilities.
FEMA will pay $5.2 million to SD Biosensor for its test kits, and $3 million to Osang, according to federal contracting records. Another company, the Virginia-based medical equipment distributor YTS Global Inc., will earn another $3.2 million to bring Covid-19 test kids to Maryland, according to federal contracting records. The additional test kits flown in from overseas “will protect citizens of the United States from potential biological harm,” FEMA noted in its purchasing records with the companies.
Earlier on Monday, an official with South Korea’s Ministry of Foreign Affairs told CNN the country will send a shipment of testing kits to the US.
When asked if reports that the US had ordered 600,000 kits, Kang said, “Yes, we’re in fact, I think these are FDA approved, preliminary approval for these, quickly approved as a result of conversation between my President and President Trump last month. I think the contracts have been signed and they should be ready for shipment anytime soon.”
Over recent weeks, the Trump administration indicated it’d be pulling back federal support of testing sites.
The so-called Community-Based Testing Sites program was intended to jumpstart initial testing capabilities to critical areas across the US, according to the agency. But given FDA approval for individuals to self-administer nasal swab tests at sites, the demand for personal protective equipment and trained health care providers will be reduced, a FEMA spokesperson said in a statement.
The administration, though, has since underscored that the federal government would continue to help states as needed. “We want to assure people and communities all across the country that we’ll continue to partner with states to the extent that they prefer us to be a part of it,” Vice President Mike Pence told reporters last week.
CNN’s Yoonjung Seo contributed to this report.